Blog - QualityStocks

MondayAug 17, 2026 9:00 am

QualityStocksNewsBreaks – Lahontan Gold Corp. (TSXV: LG) (OTCQB: LGCXF) Boosts Santa Fe Gold Equivalent Resources 22%

This article has been disseminated on behalf of Lahontan Gold Corp. and may include paid advertising. Lahontan Gold (TSXV: LG) (OTCQB: LGCXF) announced an updated Mineral Resource Estimate (“MRE”) for its Santa Fe Mine in Nevada, with project-wide pit-constrained resources increasing 22% from the 2024 MRE. The updated estimate includes 1.195 million indicated gold equivalent (“Au Eq”) ounces and 1.19 million inferred Au Eq ounces. Santa Fe deposit resources increased more than 26%, while indicated and inferred oxide resources at the Slab and York deposits increased more than 37%. The updated MRE will form the basis of a forthcoming preliminary…

FridayAug 14, 2026 3:34 pm

QualityStocksNewsBreaks – Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) Advances Nevada Strategy with Defined Resources, Positive PEA

Disseminated on behalf of Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) and may include paid advertising. Lahontan Gold (TSX.V: LG) (OTCQB: LGCXF) is positioning its Santa Fe Mine project as a Nevada-based gold development opportunity at a time when jurisdictional stability is becoming increasingly important to mining investors. The past-producing Santa Fe project contains nearly 2 million ounces of gold-equivalent resources and has a Preliminary Economic Assessment outlining a US$200 million after-tax NPV and 34.2% IRR based on a US$2,705 gold price—significantly below mid-2026 prices above US$4,100 per ounce. Lahontan has secured federal drilling approvals, expanded exploration with two rigs, advanced permitting and…

FridayAug 14, 2026 3:05 pm

QualityStocksNewsBreaks – Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H) Builds Foundation for Biomarker-Driven Cancer Therapy

Disseminated on behalf of Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H) and may include paid advertising. Onco-Innovations (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H) is advancing its precision oncology strategy through ONC010, a nanoparticle-encapsulated PNKP inhibitor being developed for biomarker-selected cancers. The company is building the manufacturing and scientific foundation needed to advance the program toward first-in-human studies, including polymer process development and analytical characterization activities with Nanosoft Polymers and metabolism studies through Nucro-Technics as part of its IND-enabling program. These efforts are designed to support scalable manufacturing, characterize ONC010’s metabolic profile and generate data for future pharmacokinetic, toxicology and regulatory activities. By combining targeted PNKP inhibition, nanoparticle…

FridayAug 14, 2026 2:16 pm

QualityStocksNewsBreaks – SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) Strengthens Defense Technology Position with AUKUS Market Access

Disseminated on behalf of SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) and may include paid advertising. SPARC AI (CSE: SPAI) (OTCQB: SPAIF) has expanded its access to allied defense markets after being registered by the Australian Government as an authorized user under the AUKUS license-free environment, streamlining eligible technology transfers among approved organizations in Australia, the United States and the United Kingdom. The milestone is particularly relevant to the company’s Overwatch platform, which provides AI-powered geolocation and target acquisition capabilities for autonomous systems operating in GPS-denied environments. Rather than manufacturing drones, SPARC AI develops software designed to integrate with existing autonomous platforms, potentially…

FridayAug 14, 2026 1:28 pm

QualityStocksNewsBreaks – Regentis Biomaterials Ltd. (NYSE American: RGNT) Builds Commercial Case for GelrinC in Multi-Billion Knee Cartilage Repair Market

Regentis Biomaterials (NYSE American: RGNT) was featured in a recent article highlighting the potential of its GelrinC cell-free hydrogel implant to address longstanding challenges in focal knee injuries through an off-the-shelf treatment designed to simplify surgical workflows, support faster recovery and promote durable tissue regeneration. The company recently received European regulatory approval for a next-generation, solvent-free manufacturing process that increases production yield by approximately 400%, supporting greater scalability and lower production costs. Regentis is also advancing surgeon training and European commercialization while progressing its pivotal U.S. Phase III SAGE trial, which is more than 50% enrolled. GelrinC’s combination of procedural simplicity, clinical…

FridayAug 14, 2026 12:59 pm

QualityStocksNewsBreaks – Wrap Technologies, Inc. (NASDAQ: WRAP) Selected to Support Florida Teacher Safety Training Program

Wrap Technologies (NASDAQ: WRAP) has been selected by WOFT Charities (“WOFT”) to provide training support for the WOFT Teacher Safety Training Program, which received a $475,000 appropriation in Florida’s fiscal year 2026-27 state budget. WRAP will support training focused on situational awareness, threat recognition, early intervention, de-escalation and avoiding physical confrontation when possible. The program will provide practical safety and preparedness training for teachers, administrators and other school personnel, including real-world scenarios and practical self-defense instruction. The $475,000 appropriation was made to WOFT, with WRAP receiving a portion based on services provided, and should not be interpreted as a direct $475,000 award or future revenue to WRAP. WRAP also has exclusive access to WOFT’s training facility,…

FridayAug 14, 2026 12:45 pm

QualityStocksNewsBreaks – Nightfood Holdings Inc. (OTCQB: NGTF) Updates Board, Executive Leadership in Support of Nasdaq Listing Application

Nightfood Holdings (OTCQB: NGTF), doing business as TechForce Robotics, announced changes to its board of directors and executive leadership and established three standing board committees in furtherance of its Nasdaq listing application. Effective Aug. 7, Darren Kenney and Ronald J. Stauber joined the five-member board, which now includes three independent directors, and the company established audit, compensation and nominating, corporate governance and compliance committees with written charters. On Aug. 10, Yury Pyatigorsky was appointed chief financial officer, succeeding Jimmy Chan, who continues to serve as CEO and secretary. The company noted there is no assurance it will meet Nasdaq listing qualifications or that Nasdaq will approve its listing. To view the full press…

FridayAug 14, 2026 12:09 pm

QualityStocksNewsBreaks – Redwood AI Corp. (CSE: AIRX) (OTCQB: RDWCF) (Frankfurt: Y0N) (WKN: A422EZ) Completes Acquisition of Quantum.IQ Technologies

This article has been disseminated on behalf of Redwood AI Corp. and may include paid advertising. Redwood AI (CSE: AIRX) (OTCQB: RDWCF) (Frankfurt: Y0N) (WKN: A422EZ) has completed its acquisition of all issued and outstanding shares of Quantum.IQ Technologies Inc., a Vancouver-based quantum cybersecurity company developing software to help organizations assess and prepare encryption systems for future quantum-enabled cyber threats. Quantum.IQ is now a wholly owned subsidiary of Redwood, expanding the company’s technology base with capabilities focused on cryptographic visibility, quantum-readiness assessment and security infrastructure planning. Quantum. IQ’s Post-Quantum Cryptography (“PQC”) platform is designed for high-security organizations in government, defence, financial services and critical infrastructure, supporting cryptographic asset discovery, Cryptographic Bill of Materials…

FridayAug 14, 2026 10:30 am

Earth Science Tech Inc. (ETST) Seeks to Implement a Unified Strategy to Unlock True Market Value and Support Shareholders

Earth Science Tech seeks to implement a unified strategy aimed at maximizing shareholder value, resolving structural hurdles, and elevating corporate governance The company will hold a virtual annual meeting on August 31, 2026, during which shareholders will vote on key initiatives that will position ETST for an uplisting to a higher-tier exchange, eliminate the structural barriers that hinder the infusion of institutional capital, and prevent stock dilution These initiatives are informed by extensive dialogue between shareholders and management leading to a consensus that the company’s current market valuation simply does not accurately reflect its financial success or future potential The…

FridayAug 14, 2026 9:50 am

QualityStocksNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Reports Lower Q2 Expenses, Advances Lucid-MS Into Phase 2

This article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising. Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) reported second-quarter 2026 financial and operational results, including a 53% year-over-year reduction in operating expenses to $2.29 million and a 47% decrease in general and administrative expenses to $1.76 million. Combined cash, cash equivalents and digital assets totaled approximately $9.5 million as of June 30, up from $4.1 million at Dec. 31, 2025, with management stating that current liquidity is sufficient to fund planned operations to at least October 2027 assuming the first-half 2026 cash burn rate. Subsequent to…

Site Search

Company Search